2013 Annual Meeting | S38 - Infections: HIV
| 04:00 PM - 05:30 PM | Abstract |
001 - Pathways to Neurodegeneration: The Effects of HIV and Aging on Resting State fcMRI
Jewell Thomas |
| 04:00 PM - 05:30 PM | Abstract |
002 - Prevalence and Characterization of Cerebral Vasculopathy in an HIV/AIDS Neuroimaging Cohort
Nancy Edwards, MD |
| 04:00 PM - 05:30 PM | Abstract |
003 - Abnormal Brain Pathology in Virologically Controlled HIV-Infected Individuals
Gloria Von Geldern, MD, FAAN |
| 04:00 PM - 05:30 PM | Abstract |
004 - Incidence Rates of Intracerebral Hemorrhage Are Increased in Young and Female HIV-Infected Individuals
Felicia Chow, MD |
| 04:00 PM - 05:30 PM | Abstract |
005 - Insufficiency of the Framingham Risk Score for Stroke Prediction in HIV-Infected Men: Long Term Follow Up in the Multi-Center AIDS Cohort Study (MACS)
Farrah J. Mateen, MD, PhD, FAAN |
| 04:00 PM - 05:30 PM | Abstract |
006 - Deep Phenotyping of Patients with Cognitive Impairment in HIV Infection
Patricia McNamara, MD, PhD |
| Avindra Nath, MD, MBBS, FAAN | The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
| Janice M. Redmond, MD | Dr. Redmond has nothing to disclose. |
| No disclosure on file | |
| Edward Fox, MD, PhD, FAAN | Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie. |
| Ned C. Sacktor, MD, FAAN | No disclosure on file |
| Steven K. Feske, MD | Dr. Feske has received publishing royalties from a publication relating to health care. |
| Carlos A. Pardo-Villamizar, MD | The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| David H. Margolin, MD, PhD | Dr. Margolin has received personal compensation for serving as an employee of Cerevance, Inc. Dr. Margolin has received personal compensation in the range of $0-$499 for serving as a Consultant for Datacubed Health. Dr. Margolin has received stock or an ownership interest from Cerevance, Inc. Dr. Margolin has received stock or an ownership interest from Datacubed Health. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care. |
| James T. Becker, PhD | No disclosure on file |
| Nerissa U. Ko, MD | The institution of Dr. Ko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Route 92, Inc. The institution of Dr. Ko has received research support from American Heart Association. The institution of Dr. Ko has received research support from NIH. The institution of Dr. Ko has received research support from NIH. |
| Colin Doherty, MD | The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland. |
| Beau M. Ances, MD, PhD, MS, FAAN | Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Ances has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Kinnard Lawyers. |
| Jeffrey Rumbaugh, MD | No disclosure on file |
| Bryan Smith, MD | Dr. Smith has nothing to disclose. |
| Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| Alastair Compston, PhD, FRCP | No disclosure on file |
| Gloria Von Geldern, MD, FAAN | The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities. |
| Nancy Edwards, MD | No disclosure on file |
| Marie F. Grill, MD | Dr. Grill has nothing to disclose. |
| Felicia Chow, MD | Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH. |
| Matthew Brier, MD, PhD | Dr. Brier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Brier has received research support from NIH. |
| Patricia McNamara, MD, PhD | No disclosure on file |
| Jewell Thomas | No disclosure on file |
| Wei He, MD | No disclosure on file |